Pulm crit Flashcards
how does NPPV improve patient with cardiogenic pulm edema?
Decreased preload and afterload
Decreased dead space ventilation, increased tidal volume and increased alveolar/minute ventilation
NPPV increases intrathoracic pressure = reduced venous return
PFTs in pulmonary arterial hypertension
normal spirometry, reduced DLCO from VQ mismatch
PFTs in asthma
airway obstruction (FEV1/FVC) <0.7 and normal DLCO
nodules with ground glass opacity: halo sign
Aspergillosis. can also have cavitations
triad for invasive pulmonary aspergillosis
fever
pleuritic chest pain
hemoptysis
tx: voriconazole
galactomannan
typically for aspergillosis
don’t be tricked though, can be false positive in histo and blasto which are assessed with serum/urine testing
define complicated pleural effusion
- appears moderate to large, free flowing or loculated
- pH <7.2, glucose <60, wbc >50k, LDH >1k
- tx: antibiotics and CHEST TUBE
serum bicarb drop in chronic respiratory alkalosis
HCO3 drops 4 mEq/L for every 10 mmHg reduction in pCO2
central bronchiectasis in asthmatic or CF
ABPA. Will also have IgE >417 and IgG, IgE to aspergillus. maybe peripheral eosinophilia
Tx with Corticosteroids + Itraconazole
things on PFT not on spirometry
- total lung capacity
- DLCO
- methacholine challenge
TLC < 80%
defines restrictive dz
FEV1/FVC < 70%
defines obstructive dz
what is a positive bronchodilator response for asthma
> 12% increase in FEV1
or absolute increase of FEV1 >200mL
T/F: Morning headaches is a sx of OSA
true
When to suspect EGPA (churg strauss)
Difficult to control ASTHMA
- > 10% peripheral eosinophilia
- mono/poly-neuropathy
- SINUS dz
- transient/migratory pulm opacities
- glomerulonephritis (KIDNEY)
ABPA does not have kidney involvement and will have bronchiectasis. but it can also present with difficult to control asthma with sinusitis and eosinophilia
ABPA vs EGPA…EGPA has kidnEy involvement
features suggestive of A1AT deficiency
(test in all new onset COPD) early onset emphysema (<45) emphysema with minimal smoking hx unexplained liver dz can have painful skin nodes (panniculitis)
isolated low DLCL
pulmonary hypertension
anemia
size threshold to tap an effusion
> 10mm
imaging modality for cteph
VQ scan more sensitive than CTa. patient need lifelong anticoag
triad for aspirin-exacerbated respiratory disease (AERD)
- chronic rhinosinusitis with polyposis
- asthma
- aspirin/NSAID sensitivity
Tx the asthma and add LT receptor antagonist (Montelukast)
workup for obesity hypoventilation syndrome
- ABG on room air (daytime hypercapnia, hypoxemia)
- Restrictive pattern on PFTs
- polysomnography
- normal TSH, no intrinsic pulm dz on CXR
clues may be dyspnea/cor pulmonale in a patient with OSA sxs, elevated serum bicarb and rbc
pleural effusion meeting lights criteria but in the setting of diuretic use
may not be accurate. Serum-effusion protein difference >3.1 or serum-effusion albumin gradient >1.2 = true transudate
mgmt of obesity hypoventilation syndrome
Positive pressure ventilation (nocturnal)
Weight reduction
avoid sedative meds
acetazolamide last line
prevention/mgmt of fat embolism
prevention: early mobilization of fractures and operative correction
tx: supportive
don’t order LE doppler , no great test
negative cytology from thoracentesis for suspected MPE
repeat thora. first study detects 60%, 3 separate can detect 90%. After this would do thoracoscopy
T/F: You can have mild to moderate pHTN in COPD and does not need specific tx
true, focus on your corticosteroids, bronchodilators and o2
differentiate intrinsic vs extrinsic restrictive lung dz
Intrinsic: DLCO low
Extrinsic: DLCO normal
differentiate Goodpasture from GPA
Goodpasture = pumonary renal syndrome = anti-GBM antibody. will not have constitutional vasculitis sxs (fever, wt loss, arthralgia, fatigue) and also no ENT sxs. . Bx shows linear deposits of IgG. Tx with plasmapharesis + steroid/cyclophosphamide
GPA is vasculitis, CXR will have nodules/cavitations and bx shows granuloma in artery, perivascular area. ANCA. Tx steroid/cyclophophamide or rituximab
how do you treat acute asthma attack?
ED:
- repeat SABA
- O2 to main >92%
- PO steroids (IV if can’t take PO, or respiratory distress)
- inhaled ipratropium prn
DC:
- ICS if they don’t have one
- PO steroids for total 3-7 day course
- asthma action plan
Asthma tx if patients don’t have daily sxs
This is intermittent or mild persistent (step 1, step 2)
Step 1: SABA prn
Step 2: Add lose dose ICS
Asthma tx once patients have daily sxs
Step 3 (moderate persistent): ICS (low, medium dose) + LABA
Step 4 severe persistent): Add high dose ICS + LABA or LAMA
Later therapy = Omalizumab (MAB to IgE) and Mepolizumab (Anti IL5…if there is peripheral eosinophilia)
pleural effusion with very high LDH
- Rheumatoid (yellow-greenish, lymphocyte predominant)
- Empyema (purulent, neutrophilic)
silicosis
- micronodules in upper lobes
- exposures: coal mining, hard rock mining, sand blasting, quarrying, masonry, ceramic/glass manufacturing
- increased risk of lung cancer and TB, screen for TB @ dx
- associated with scleroderma and rheumatoid arthritis
PFTs in ILD
Restrictive pattern:
- Reduced FEV1, FVC and TLC, DLCO
- normal FEV1/FVC ratio
PFTs in Asthma
Obstructive pattern with High TLC, normal DLCO
PFTs in pHTN
isolated reduced DLCO
DLCO in asthma and copd
Asthma: NORMAL DLCO
COPD: DLCO can be normal or low depending on stage (emphsyma is destructive and will decrease DLCO)
T/F: Reactive airway disease may have obstructive PFTs and can be dx with methacholine challenge
true, its a nonimmune asthma-like illness occurring after single high-level exposure to pulmonary irritant
First line tx for lung abscess
Unasyn or Carbapenem. Don’t need to aspirate, will respond well to abx
What does GOLD criteria take into account for management?
Symptom burden and risk of exacerbation.
Thus, airflow limitation (FEV1) plays a minimal role in determining therapy
first line therapy for COPD patients GOLD category B or higher (moderate-severe sxs and 1 or less exacerbation/year)
LAMA (tiotropium, umeclinidinum, aclidinium, glycopyrrolate)
or
LABA (salmeterol)
T/F: Clubbing is not associated with COPD
true. think bronchiectasis, right to left shunt, malignancy, IPF, asbestosis, CF
T/F: EGPA will have poorly controlled asthma
true. Other features include peripheral eosinophilia >10%, peripheral neuropathy (mononeuritis monoplex), migratory pulmonary infiltrates on CXR and necrotizing glomerulonephritis
EGPA
T/F: Constitutional sxs are typically seen in vasculitis
true